Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar with Concurrent Chemoradiotherapy for Locally Advanced Cervical Carcinoma
NCT03086681Phase 2Completed
- Start
- Apr 2017
- Primary completion
- Sep 2020
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2, randomised trial of endostar in cervical carcinoma (2 arms). Primary endpoint: short-time effect at 3 months. Started Apr 2017; status: completed.
02
Drugs
endostar
03
Conditions
cervical carcinoma
Beyond the preview
Go deeper on NCT03086681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03086681.